Dendreon Corp

NASDAQ: DNDN
Source: ThinkstockDendreon Corp. (NASDAQ: DNDN) has been down and out, and now the company is going to try a restructuring strategy after earnings, in an effort to save it from the worst case...
Source: Jon OggDendreon Corp. (NASDAQ: DNDN) is by almost all measurements nothing short of a total failure of a biotech or biohealth stock. Despite having a solid prostate cancer treatment in...
Source: Jon OggIt is an August Friday, and there are a surprising number of research calls before the week ahead, which is usually the slowest week of the year other than the one between Christmas...
August 9, 2013: U.S. equity markets opened lower this morning and bounced around below the break-even line most of the day. The day’s biggest economic news came from China, where the CPI rose 2.7%...
Source: via Wikimedia CommonsDendreon Corp. (NASDAQ: DNDN) has been facing problems getting its Provenge sales for advanced metastatic prostate cancer through to the market. Even a direct to consumer...
U.S. equity markets opened mixed this morning and failed to find a direction driver throughout the trading day. In Europe, Germany reported a stronger-than-expected trade surplus, while the U.K.’s...
Source: Jon OggInvestors frequently see analyst upgrades and Buy ratings from Wall Street research calls, but they often do not get to see the so-called Sell ratings. 24/7 Wall St. reviews many fresh...
Source: ThinkstockDendreon Corp. (NASDAQ: DNDN) just cannot catch a break. Despite having what was supposed to be one of the best late-stage prostate treatments in Provenge, sales just are not coming...
Source: Jon OggThese are some of this Tuesday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls.Aeropostale Inc. (NYSE: ARO) named Bear of the Day as expensive...
Source: Jon OggThe week ahead is going to have many key earnings reports. Retail is heavily represented, while technology and banking giants are non-existent. Some of these are stocks which can move...
Source: Jon OggThese are some of this Thursday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls.CenturyLink Inc. (NYSE: CTL) cut to Neutral at J.P. Morgan, cut...
The stock market is down Monday, with the Dow Jones Industrial Average down 0.09%, the Nasdaq down 0.57% and the S&P 500 down 0.33%. Today’s winners include a smartphone manufacturer...
Source: ThinkstockCancer ranks on the list of global killers as number two. Over the years, great strides have been made not only in cancer treatment but in survival rates for many different forms...
Source: ThinkstockDendreon Corp. (NASDAQ: DNDN) is seeing shares surge higher on Friday on an analyst upgrade. The move higher is part because Dendreon has a long history of boom and bust with large...
Source: Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research firms this Friday.ADTRAN Inc. (NASDAQ: ADTN) maintained Underperform but named Bear...